NCT01020370View on ClinicalTrials.gov

Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies

CompletedOBSERVATIONAL
Timeline

Start Date

Not specified

Conditions
Multiple Sclerosis
All Listed Sponsors
lead

Wayne State University

OTHER

NCT01020370 - Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies | Biotech Hunter | Biotech Hunter